
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long non-coding RNA mediated drug resistance in breast cancer
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 95
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 95
Showing 26-50 of 95 citing articles:
Insights into the role of non-coding RNAs in the development of insecticide resistance in insects
Huamei Xiao, Chunhui Ma, Ruizhi Peng, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 5
Huamei Xiao, Chunhui Ma, Ruizhi Peng, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 5
Exosomes of immune cell origin and their therapeutic potential for tumors
Hongru Ai, Yitan Zou, Xinya Zheng, et al.
View (2024)
Open Access | Times Cited: 5
Hongru Ai, Yitan Zou, Xinya Zheng, et al.
View (2024)
Open Access | Times Cited: 5
HOTAIR: A key regulator of the Wnt/β-catenin signaling cascade in cancer progression and treatment
Mohammed Ageeli Hakami, Ali Hazazi, Osama Abdulaziz, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154957-154957
Closed Access | Times Cited: 11
Mohammed Ageeli Hakami, Ali Hazazi, Osama Abdulaziz, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154957-154957
Closed Access | Times Cited: 11
Non-coding RNA and drug resistance in head and neck cancer
Yulong Zhang, Yingming Peng, Bingqin Lin, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
Yulong Zhang, Yingming Peng, Bingqin Lin, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
Innovative Approaches in Atherosclerosis Treatment: Harnessing Traditional Chinese Medicine to Target Long Non-Coding RNAs
Xiaofang Chen, Wen‐yan Ding, Yifan Liu, et al.
Phytomedicine (2025) Vol. 139, pp. 156488-156488
Closed Access
Xiaofang Chen, Wen‐yan Ding, Yifan Liu, et al.
Phytomedicine (2025) Vol. 139, pp. 156488-156488
Closed Access
Layered Double Hydroxide LDH-Loaded miR-141–3p Targets RAB10 Suppressing Cellular Autophagy to Reverse Paclitaxel Resistance in Breast Cancer
Shuang Tao, Yuxin Ji, Ruonan Li, et al.
ACS Omega (2025) Vol. 10, Iss. 6, pp. 5886-5899
Open Access
Shuang Tao, Yuxin Ji, Ruonan Li, et al.
ACS Omega (2025) Vol. 10, Iss. 6, pp. 5886-5899
Open Access
STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis
Yihui Pan, Shuang Liu, Guannan Shu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Yihui Pan, Shuang Liu, Guannan Shu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Epigenetic Landscapes of Aging in Breast Cancer Survivors: Unraveling the Impact of Therapeutic Interventions—A Scoping Review
Nikita Nikita, Zhengyang Sun, Swapnil Sharma, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 866-866
Open Access
Nikita Nikita, Zhengyang Sun, Swapnil Sharma, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 866-866
Open Access
Functions and Therapeutic Potentials of Long Noncoding RNA in Skeletal Muscle Atrophy and Dystrophy
Yidi Zhang, Teng Wang, Ziang Wang, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access
Yidi Zhang, Teng Wang, Ziang Wang, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access
Unravelling the epigenetic based mechanism in discovery of anticancer phytomedicine: Evidence based studies
Bushra Bashir, Pranshul Sethi, Satyajit Panda, et al.
Cellular Signalling (2025), pp. 111743-111743
Closed Access
Bushra Bashir, Pranshul Sethi, Satyajit Panda, et al.
Cellular Signalling (2025), pp. 111743-111743
Closed Access
Role of long non-coding RNAs in the regulation of ferroptosis in tumors
Ying Ju, Yuanhao Lv, Xu Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ying Ju, Yuanhao Lv, Xu Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression
Yongsheng Zhang, Yanjiao Xu, Yanping Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yongsheng Zhang, Yanjiao Xu, Yanping Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Paclitaxel Resistance in Breast Cancer: Current Challenges and Recent Advanced Therapeutic Strategies
Heidi A Abouzeid, Loay Kassem, Xumei Liu, et al.
Cancer Treatment and Research Communications (2025), pp. 100918-100918
Open Access
Heidi A Abouzeid, Loay Kassem, Xumei Liu, et al.
Cancer Treatment and Research Communications (2025), pp. 100918-100918
Open Access
Regulation of immune-mediated chemoresistance in cancer by lncRNAs: an in-depth review of signaling pathways
Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Subasini Uthirapathy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Subasini Uthirapathy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
To Predict the Prognosis and Immunological Characteristics of Pancreatic Cancer Based on Disulfide-Death Gene Death-Related lncRNA
Zhihong Liao, Tianxing Dai, F.T. Yuan, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 924-924
Open Access
Zhihong Liao, Tianxing Dai, F.T. Yuan, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 924-924
Open Access
HDAC4 Super-Enhancer Drives CEBPB-Mediated TWIST2 Transcription to Promote Chemoresistance in LUAD
Min Jiang, Kai Zhang, Guohao Wei, et al.
Cancer Letters (2025), pp. 217716-217716
Closed Access
Min Jiang, Kai Zhang, Guohao Wei, et al.
Cancer Letters (2025), pp. 217716-217716
Closed Access
Extracellular vesicles in triple-negative breast cancer: current updates, challenges and future prospects
Prashant Tiwari, Anis Ahmad Chaudhary, Saurabh Gupta, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Prashant Tiwari, Anis Ahmad Chaudhary, Saurabh Gupta, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
PTPRG-AS1 regulates the KITLG/KIT pathway through the ceRNA axis to promote the malignant progression of gastric cancer and the intervention effect of Compound Kushen injection on it
Chao Wu, Yifei Gao, Zhengsen Jin, et al.
Pharmacological Research (2025) Vol. 215, pp. 107743-107743
Open Access
Chao Wu, Yifei Gao, Zhengsen Jin, et al.
Pharmacological Research (2025) Vol. 215, pp. 107743-107743
Open Access
Long noncoding RNA UCA1 knockdown inhibits cisplatin-resistant cervical cancer tumorigenesis via the miR-195-5p/IKBKB axis
Wang Bi, Ling Li, Zhengyu Wu, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Wang Bi, Ling Li, Zhengyu Wu, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Co-delivery of doxorubicin and quercetin by Janus hollow silica nanomotors for overcoming multidrug resistance in breast MCF-7/Adr cells
Haofei Zhou, Ye Yuan, Zhexu Wang, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2022) Vol. 658, pp. 130654-130654
Closed Access | Times Cited: 16
Haofei Zhou, Ye Yuan, Zhexu Wang, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2022) Vol. 658, pp. 130654-130654
Closed Access | Times Cited: 16
Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Zhijie Xu, Zhiyang Zhou, Xiaoxin Yang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Zhijie Xu, Zhiyang Zhou, Xiaoxin Yang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Clinical implications of lncRNA LINC-PINT in cancer
Ihtisham Bukhari, Muhammad Riaz Khan, Fazhan Li, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
Ihtisham Bukhari, Muhammad Riaz Khan, Fazhan Li, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
Identification of associations between lncRNA and drug resistance based on deep learning and attention mechanism
Meihong Gao, Xuequn Shang
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Meihong Gao, Xuequn Shang
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Long Noncoding RNAs in Taxane Resistance of Breast Cancer
Hailong Chen, Mengwen Zhang, Yongchuan Deng
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12253-12253
Open Access | Times Cited: 8
Hailong Chen, Mengwen Zhang, Yongchuan Deng
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12253-12253
Open Access | Times Cited: 8
Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer
Junyuan Xie, Li Gan, Bingjian Xue, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Junyuan Xie, Li Gan, Bingjian Xue, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7